Leslie Tari - Mar 31, 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: CHIEF SCIENTIFIC OFFICER
Signature: /s/ Leslie Tari
Stock symbol: CDTX
Transactions as of: Mar 31, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/4/2022, 05:07 PM
Previous filing: Jan 7, 2022
Next filing: Sep 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+52.5K	+33.78%	$0.00	208K	Mar 31, 2022	Direct	F1
holding	CDTX	Common Stock						13.3K	Mar 31, 2022	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+105K		$0.00	105K	Mar 31, 2022	Common Stock	105K	$0.83	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
F2	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.